Product NDC: | 0069-0076 |
Proprietary Name: | paclitaxel |
Non Proprietary Name: | paclitaxel |
Active Ingredient(s): | 100 mg/16.7mL & nbsp; paclitaxel |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0076 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091540 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110930 |
Package NDC: | 0069-0076-01 |
Package Description: | 16.7 mL in 1 VIAL (0069-0076-01) |
NDC Code | 0069-0076-01 |
Proprietary Name | paclitaxel |
Package Description | 16.7 mL in 1 VIAL (0069-0076-01) |
Product NDC | 0069-0076 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | paclitaxel |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110930 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | PACLITAXEL |
Strength Number | 100 |
Strength Unit | mg/16.7mL |
Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |